Kieran Gallahue - Edwards Lifesciences Independent Director

EW Stock  USD 70.20  0.31  0.44%   

Director

Mr. Kieran T. Gallahue is an Independent Director of the Edwards Lifesciences Corporationrationration. Mr. Gallahue provides valuable insights and direction to our Board gained through extensive executive management experience at medical technology companies. His leadership roles on other public company boards and committees and prior experience as a public company chief financial officer also enables him to contribute valuable financial and accounting perspectives to our Board and Audit Committee. since 2015.
Age 57
Tenure 9 years
Professional MarksMBA
Address One Edwards Way, Irvine, CA, United States, 92614
Phone949 250 2500
Webhttps://www.edwards.com

Edwards Lifesciences Management Efficiency

The company has Return on Asset (ROA) of 0.1065 % which means that for every $100 of assets, it generated a profit of $0.1065. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1914 %, which means that it produced $0.1914 on every 100 dollars invested by current stockholders. Edwards Lifesciences' management efficiency ratios could be used to measure how well Edwards Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.1 in 2024. Return On Capital Employed is likely to drop to 0.14 in 2024. At this time, Edwards Lifesciences' Intangibles To Total Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to climb to 4.91 in 2024, whereas Debt To Assets are likely to drop 0.06 in 2024.
Edwards Lifesciences Corp reports 694.9 M of total liabilities with total debt to equity ratio (D/E) of 0.11, which may suggest the company is not taking enough advantage from financial leverage. Edwards Lifesciences Corp has a current ratio of 3.75, indicating that it is in good position to pay out its debt commitments in time. Note however, debt could still be an excellent tool for Edwards to invest in growth at high rates of return.

Similar Executives

Found 14 records

DIRECTOR Age

Andrew BranchflowerFevertree Drinks Plc
44
Vicki PalmerHaverty Furniture Companies
67
Meghan JoyceBoston Beer
36
Michael SpillaneBoston Beer
64
Cynthia FisherBoston Beer
59
Al TrujilloHaverty Furniture Companies
61
Mylle MangumHaverty Furniture Companies
72
John GloverHaverty Furniture Companies
73
G HoughHaverty Furniture Companies
66
JeanMichel ValetteBoston Beer
60
Josuke KimuraSuntory Beverage Food
57
Arnold TinterBarfresh Food Group
79
Frank FallwellSNDL Inc
N/A
Yuji YamazakiSuntory Beverage Food
66
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 15700 people. Edwards Lifesciences Corp (EW) is traded on New York Stock Exchange in USA. It is located in One Edwards Way, Irvine, CA, United States, 92614 and employs 19,800 people. Edwards Lifesciences is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Edwards Lifesciences Corp Leadership Team

Elected by the shareholders, the Edwards Lifesciences' board of directors comprises two types of representatives: Edwards Lifesciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Edwards. The board's role is to monitor Edwards Lifesciences' management team and ensure that shareholders' interests are well served. Edwards Lifesciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Edwards Lifesciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul LaViolette, Independent Director
Larry Wood, Corporate Vice President - Transcatheter Aortic Valve Replacement
Leslie Heisz, Independent Director
Catherine Szyman, Corporate Vice President - Critical Care
Arnold Pinkston, Corporate Counsel
Arnold JD, Corporate Counsel
Steven Loranger, Independent Director
Scott Ullem, Chief Financial Officer, Corporate Vice President
Kieran Gallahue, Independent Director
Nicholas Valeriani, Independent Director
Heisz Stone, Independent Director
Mark Wilterding, Vice Relations
MD FACC, Corporate Officer
Angela Fuente, Director Engineering
Martha Marsh, Lead Independent Director
Daveen Chopra, Corporate Vice President - Surgical Structural Heart
Huimin Wang, Corporate Vice President - Japan, Asia and Pacific
JeanLuc Lemercier, Corporate Vice President - EMEA (Europe, Middle East and Africa)
Christine McCauley, Corporate Resources
William Link, Independent Director
Gary Sorsher, Senior Compliance
Ramona Sequeira, Independent Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
Daniel Lippis, Greater Japan
Donald Bobo, Corporate Vice President - Strategy and Corporate Development
Todd Brinton, Co Officer
Dirksen Lehman, Corporate Affairs
Finn Haley, Vice Development
Andrew Dahl, Senior Officer
Michael Mussallem, Chairman of the Board, Chief Executive Officer

Edwards Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Edwards Lifesciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.